Financial Performance - The company's operating revenue for Q1 2017 was ¥1,248,789,207.89, representing a 20.26% increase compared to ¥1,038,364,832.79 in the same period last year[9] - Net profit attributable to shareholders was ¥59,484,864.25, an increase of 80.02% from ¥33,043,336.99 year-on-year[9] - The net profit after deducting non-recurring gains and losses was ¥53,719,547.43, up 89.18% from ¥28,396,100.39 in the previous year[9] - The basic earnings per share increased to ¥0.081, a rise of 68.75% compared to ¥0.048 in the same period last year[9] - Operating profit increased by 126.63% year-on-year, driven by growth in viscose gross profit[17] - Net profit increased by 118.20% year-on-year, attributed to growth in viscose profits and steady growth in the health industry[17] - Total operating revenue for the current period reached ¥1,234,084,789.95, a significant increase from ¥860,088,504.14 in the previous period, representing a growth of approximately 43.5%[48] - Net profit for the current period was ¥59,467,619.02, compared to ¥27,254,333.39 in the previous period, indicating an increase of about 118.5%[45] - Total comprehensive income for the current period was ¥59,467,619.02, compared to ¥27,254,333.39 in the previous period, showing an increase of approximately 118.5%[45] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,590,220,247.35, an increase of 11.34% from ¥4,122,526,891.08 at the end of the previous year[9] - The net assets attributable to shareholders were ¥1,247,594,657.13, reflecting a 4.80% increase from ¥1,190,427,820.38 at the end of the previous year[9] - Current total assets amounted to ¥4,590,220,247.35, up from ¥4,122,526,891.08 at the beginning of the period, reflecting growth in asset base[34] - Current liabilities increased to ¥3,074,625,680.30 from ¥2,672,252,449.64, showing a rise in short-term financial obligations[32] - The total liabilities reached ¥3,186,304,824.67, compared to ¥2,785,624,087.42 previously, indicating a rise in overall debt levels[32] - The company’s total equity increased to ¥1,403,915,422.68 from ¥1,336,902,803.66, demonstrating a strengthening of the equity position[34] Cash Flow - The company reported a net cash flow from operating activities of -¥198,651,725.24, a significant decrease of 378.90% compared to ¥71,226,244.75 in the same period last year[9] - Cash flow from operating activities decreased by 378.90% year-on-year, mainly due to reduced inflows and increased expenditures[17] - The company reported a net cash outflow from operating activities of ¥198,651,725.24, compared to a net inflow of ¥71,226,244.75 in the previous period[53] - Cash inflow from operating activities totaled 607,410,337.90 yuan, down from 658,152,988.05 yuan in the previous period[57] - Cash outflow for purchasing goods and services was 780,234,014.36 yuan, an increase from 712,378,739.33 yuan in the previous period[57] - Financing activities generated a net cash flow of 137,105,833.33 yuan, an increase from 29,214,885.42 yuan in the previous period[59] - The company experienced a net increase in cash and cash equivalents of -75,559,316.36 yuan, compared to -29,996,972.89 yuan in the previous period[59] Shareholder Information - The top shareholder, Aoyang Group Co., Ltd., holds 49.10% of the shares, with a total of 360,130,731 shares[13] - The company completed a capital increase of 50 million yuan from a strategic investor, raising its registered capital to 69,773 million yuan[19] Government Support - The company received government subsidies amounting to ¥12,791,130.93 during the reporting period[10] - The company received tax refunds that increased by 35.65% year-on-year, due to higher government tax refunds received[17] Operational Expenses - The company incurred sales expenses of ¥38,395,131.57, which is an increase from ¥32,495,588.94, reflecting a rise of about 18.0%[43] - Management expenses were reported at ¥46,350,296.86, slightly up from ¥44,333,087.50, indicating an increase of about 4.5%[43] Investment Activities - The company’s long-term investments in equity increased to ¥1,161,617,547.91 from ¥1,141,336,281.54, suggesting a focus on strategic investments[34] - Investment activities resulted in a net cash outflow of -21,545,580.00 yuan, compared to a net inflow of 2,264,928.48 yuan in the previous period[59] Audit Information - The company did not undergo an audit for the first quarter report[60]
澳洋健康(002172) - 2017 Q1 - 季度财报